Narcotics, benzodiazepines, stimulants, and gabapentin: policies, initiatives, and practices across Canada, 2014
CADTH
Record ID 32015000148
English
Authors' recommendations:
The survey of Canada's publicly funded drug plans, colleges of physicians and surgeons, and colleges of pharmacists shows that jurisdictions have established multiple avenues to address the issue of prescription drug abuse.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/products/environmental-scanning/environmental-scans/es0285
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Canada
- Narcotics
- Benzodiazepines
- gamma-Aminobutyric Acid
- Cyclohexanecarboxylic Acids
- Central Nervous System Stimulants
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.